ALPS Medical Breakthroughs ETF
SBIO
40 hedge funds and large institutions have $38.8M invested in ALPS Medical Breakthroughs ETF in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 16 reducing their positions, and 13 closing their positions.
272% more call options, than puts
Call options by funds: $201K | Put options by funds: $54K
0.56% more ownership
Funds ownership: 40.26% → 40.82% (+0.56%)
13% less capital invested
Capital invested by funds: $44.6M → $38.8M (-$5.87M)
18% less funds holding
Funds holding: 49 → 40 (-9)
63% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 16
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Davenport & Co
Richmond,
Virginia
|
+$2.34M |
| 2 |
SFS
Strategic Financial Services
Utica,
New York
|
+$864K |
| 3 |
RI
Ridgewood Investments
Springfield,
New Jersey
|
+$851K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$759K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$631K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.35M |
| 2 |
AC
ASB Consultores
Aventura,
Florida
|
-$783K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$672K |
| 4 |
Morgan Stanley
New York
|
-$635K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$580K |
SBIO Hedge Fund Activity: Q1 2023 in Review
40 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q1 2023, worth a combined $38.8M — down 13% from $44.6M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of SBIO and 4 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 6 added.
The largest buyer was Davenport & Co, adding an estimated $2.34M. The largest seller was Royal Bank of Canada, cutting an estimated $1.35M.
- 40 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q1 2023, down from 49 in Q4 2022.
- Funds reported $38.8M of ALPS Medical Breakthroughs ETF stock for Q1 2023, down 13% quarter-over-quarter.
- 4 funds opened new ALPS Medical Breakthroughs ETF positions in Q1 2023 and 13 closed out, a net change of -9 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q1 2023 was Davenport & Co, an estimated $2.34M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q1 2023 was Royal Bank of Canada, an estimated $1.35M sold.
Based on aggregated 13F filings for Q1 2023.